Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

European Medicines Agency
News & Press Releases
News: EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19 (new)
CHMP, Last updated: 16/12/2021

 

 

News: Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer (new)
CHMP, Last updated: 16/12/2021

News: EMA recommends approval for use of Kineret in adults with COVID-19 (new)
CHMP, Last updated: 16/12/2021

 

 

News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy (new)
CHMP, Last updated: 16/12/2021

News: EMA launches the Regulatory Science Research Needs initiative (new)
Last updated: 15/12/2021

News: COVID-19 Vaccine Janssen: EMA recommendation on booster dose (new)
CHMP, Last updated: 15/12/2021

News: EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 (new)
Last updated: 14/12/2021

 

 

::::::

 

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
News
Epidemiological update: Omicron variant of concern (VOC) – data as of 16 December 2021 (12:00)
Epidemiological update – 16 Dec 2021
As of 16 December and since 15 December 2021, 529 additional SARS-CoV-2 Omicron variant of concern (VOC) cases have been confirmed in the European Union and European Economic Area (EU/EEA), contributing to an overall total of 3 158 confirmed cases so far.

News
ECDC publishes new risk assessment on further emergence of Omicron variant
News story – 15 Dec 2021
ECDC has published the eighteenth update of its rapid risk assessment (RRA). This RRA extends the assessment on the circulation of the Delta variant of concern (VOC) and projections for the festive period that was published on 24 November 2021, including the emergence and spread of the Omicron VOC. The inclusion of updated forecasts developed for this risk assessment are informed by the latest evidence on Omicron VOC epidemiology, transmissibility, severity, and immune escape.

Publication
Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing Delta VOC transmission in the EU/EEA, 18th update
Risk assessment – 15 Dec 2021
The risk to public health posed by the spread of the Omicron VOC in the context of ongoing Delta VOC transmission in the EU/EEA is assessed in this update. The Delta VOC remains the most prevalent variant, but community-associated spread of the Omicron VOC is occurring in the EU/EEA and the Omicron VOC will probably become dominant in early 2022, based on mathematical modelling predictions. We therefore assess the probability of further spread of the Omicron variant in the EU/EEA as VERY HIGH.

News
Epidemiological update: Omicron variant of concern (VOC) – data as of 15 December 2021 (12:00)
Epidemiological update – 15 Dec 2021

 

 

::::::

Accessed 18 Dec 2021
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Press release 17 December 2021
Horn of Africa drought: EU allocates €21.5 million in additional humanitarian funding
The Commission has allocated €21.5 million in additional humanitarian funding to the Horn of Africa to help the region fight off what is rapidly becoming its worst drought in decades, already affecting millions of people.

Press release 16 December 2021
European Commission obtains further acceleration of deliveries of vaccine doses to Member States
The European Commission has reached an agreement with Moderna to accelerate the delivery of its mRNA vaccine to EU Member States that have a short-term need, in particular Germany.

Press release 14 December 2021
The European Commission joins Romania’s efforts in the vaccination communication campaign
The European Commission and its Representation in Romania will launch a communication campaign on vaccination on 14 December to support the efforts of national authorities in the fight against the COVID-19 pandemic.